Denali Therapeutics Inc. SEC filings DNLI
Denali Therapeutics Inc. has 789 filings in SEC EDGAR's recent list, going back to Sep 8, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Acquisition or sale of assets
|
Jul 28, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 18, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 22, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Agreement ended
|
Apr 3, 2026 | Apr 3, 2026 |
| 8-K |
Current report
New debt, Regulation FD disclosure
|
Mar 31, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 10, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 4, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 4, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 14, 2025 | Oct 13, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 7, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Jun 3, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2025 | Apr 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 18, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2024 | Oct 10, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 31, 2024 | May 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 16, 2024 | Feb 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Material agreement
|
Aug 21, 2023 | Aug 17, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Other events
|
Jun 20, 2023 | Jun 20, 2023 |
| 8-K |
Current report
Other events
|
Jun 5, 2023 | Jun 5, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 20, 2022 | Oct 19, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 18, 2022 | Oct 18, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 5, 2022 | Jul 4, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2022 | Jun 2, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 16, 2022 | Mar 14, 2022 |
| 8-K |
Current report
Material agreement
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 14, 2022 | Feb 14, 2022 |
| 8-K |
Current report
Other events
|
Feb 10, 2022 | Feb 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 7, 2022 | Feb 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 17, 2021 | Nov 17, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Other events
|
Jul 26, 2021 | Jul 25, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Results of operations
|
May 3, 2021 | May 3, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Other events
|
Feb 12, 2021 | Feb 12, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Feb 10, 2021 | Jan 8, 2021 |
| 8-K |
Current report
Other events
|
Feb 5, 2021 | Feb 4, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 11, 2021 | Jan 8, 2021 |
| 8-K |
Current report
Other events
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Oct 7, 2020 | Oct 4, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 20, 2020 | Aug 17, 2020 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Aug 20, 2020 | Jun 3, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2020 | Aug 7, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 6, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2020 | Jun 3, 2020 |
| 8-K |
Current report
Results of operations, Other events
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Results of operations, Other events
|
Apr 2, 2020 | Apr 2, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2020 | Feb 27, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 29, 2020 | Jan 28, 2020 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 27, 2020 | Jan 27, 2020 |
| 8-K |
Current report
Other events
|
Jan 14, 2020 | Jan 14, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2019 | Nov 6, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2019 | Aug 6, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2019 | May 30, 2019 |
| 8-K |
Current report
Results of operations
|
May 8, 2019 | May 8, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2019 | Mar 12, 2019 |
| 8-K |
Current report
Other events
|
Jan 4, 2019 | Dec 19, 2018 |
| 8-K |
Current report
Other events
|
Nov 19, 2018 | Nov 19, 2018 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 8, 2018 | Nov 6, 2018 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 1, 2018 | Oct 29, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2018 | Aug 9, 2018 |
| 8-K |
Current report
Other events
|
Aug 1, 2018 | Aug 1, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2018 | Jun 13, 2018 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
May 30, 2018 | May 30, 2018 |
| 8-K |
Current report
Results of operations
|
May 11, 2018 | May 11, 2018 |
| 8-K |
Current report
Material agreement, New debt
|
May 7, 2018 | May 2, 2018 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 19, 2018 | Mar 16, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 5, 2018 | Jan 3, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Dec 12, 2017 | Dec 12, 2017 |
Showing 102 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DNLI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1714899
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.